Purpose Attention deficit hyperactivity disorder (ADHD) affects children and adults and is
treated with both pharmacologic and nonpharmacologic interventions. Multiple drugs are …

Introduction: The prevalence of the attention deficit hyperactivity disorder (ADHD) in
childhood is 3% to 5%; apparently, its expression during adolescence is not lower. Around …

Objective To assess ADHD symptoms after switching from Methylphenidate Immediate-
release (MPH-IR) to Methylphenidate Spheroidal Oral Drug Absorption System (MPH …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
mental disorders during childhood, characterized by the core symptoms of hyperactivity …

We review the effect of methylphenidate, focusing on Osmotic-controlled Release Oral
delivery System (OROS) methylphenidate, on cardiovascular system, appetite and growth …

Objective: Attention-deficit/hyperactivity disorder (ADHD) is a common, life-long condition
associated with major functional impairment, and remission is the primary goal of treatment …

Objective To assess and compare the effectiveness and safety of methylphenidate
immediate-release tablets (IR-MPH), methylphenidate controlled-release tablets (OROS …

研究目的: Atomoxetine 和methylphenidate 是台灣以及許多其他國家用於治療注意力不足過動
症(Attention Deficit/Hyperactivity Disorder, ADHD) 僅有的兩種藥物. 雖然這兩種藥物具有相似 …

Background: This study aimed to evaluate the efficacy and safety of long-acting versus short-
acting methylphenidate on the symptoms of attention deficit hyperactivity disorder (ADHD) in …

Background: Attention-deficit/hyperactivity disorder (ADHD) is a common behavioural
disorder in childhood. The psychostimulant methylphenidate hydrochloride (MPH) is one of …